Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | MMP1 | P03956 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | SRC | P12931 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | APP | P05067 | 2/20 | 1.00 |
| ▸ | LCK | P06239 | 2/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | KDM1A | O60341 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 1.00 |
| ▸ | JUN | P05412 | 1/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rosmarinic Acid SCHEMBL29482753 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL29482752 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL29438187 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL29371115 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL7458453 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL1650675 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL19348 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL15263386 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL29453379 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 | |
| Rosmarinic Acid SCHEMBL15263387 | 1.00 | TDP1 (1.00) | TDP1MMP1KDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352604-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SLEEP AND MANAGING STRESS | KARALLIEF INC (US) | 2025-11-20 | — | — | US | claimed |
| EP-3829599-B1 | COMBINATION FOR USE IN THE TREATMENT OF EXTRA-OESOPHAGEAL SYMPTOMS OF GASTRIC REFLUX | DRUGS MINERALS AND GENERICS ITALIA S R L IN FORMA ABBREVIATA D M G ITALIA S R L (IT) | 2024-12-04 | — | — | EP | claimed |
| US-20250352604-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SLEEP AND MANAGING STRESS | KARALLIEF INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-3829599-B1 | COMBINATION FOR USE IN THE TREATMENT OF EXTRA-OESOPHAGEAL SYMPTOMS OF GASTRIC REFLUX | DRUGS MINERALS AND GENERICS ITALIA S R L IN FORMA ABBREVIATA D M G ITALIA S R L (IT) | 2024-12-04 | — | — | EP | disclosed |
| US-20240041868-A1 | Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors | Pathways Neuro Pharma, Inc. | 2024-02-08 | — | — | US | disclosed |
| US-20230321197-A1 | Polyphenolic Insulin | KIMBALL WESTWARD LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-11701353-B2 | Methods, compositions, and uses of novel FYN kinase inhibitors | Pathways Neuro Pharma, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041868-A1 | Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors | FYN, LCK, PTK2B | TDP1 602/4885MMP1 3507/4885KDM4E 1800/4885 |
| US-11701353-B2 | Methods, compositions, and uses of novel FYN kinase inhibitors | FYN, LCK, PTK2B | TDP1 602/4885MMP1 3507/4885KDM4E 1800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.